ENGN as of Nov 4 · 08:19 ET
ENGNNasdaqBiological Products, (No Diagnostic Substances)
enGene Therapeutics Inc. · Brief
Next report
47 days
Dec 21 · after closeest.Q4 FY26
Expected move
No implied move.
—≥ implied
Q3 FY26—▲+5.49%—
quarterimplied−10%0+10%realized×
Q3 FY26—▲+5.49%—
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close
Bull & bear
Dec 21 report · est.—
Linked exposure
ENGN report sessionNo linked exposure.
No changes.
Your note
privateThesis 0 · Decisions 0 · Observations 0
No thesis.